Bill > SJR32

This resolution seeks to designate the first full week in May as Tardive Dyskinesia (TD) Awareness Week, highlighting the importance of understanding and addressing this neurological condition. The resolution provides context about TD, which is a side effect of prolonged antipsychotic medication use characterized by uncontrollable, repetitive body movements. It notes that TD disproportionately affects certain populations, including individuals over 55, Black individuals, women, and those with mood or substance use disorders. The resolution emphasizes that approximately 60 percent of an estimated 800,000 U.S. adults with TD remain undiagnosed, and even mild symptoms can significantly impact a person's physical, social, and emotional well-being. By promoting awareness, the resolution aims to encourage routine TD screening, as recommended by the American Psychiatric Association, and to ensure that healthcare providers and patients understand the risks associated with antipsychotic medications. The ultimate goal is to improve early detection, intervention, and treatment options for individuals living with TD, ultimately enhancing their quality of life.

https://docs.legis.wisconsin.gov/2025/proposals/reg/sen/joint_resolution/sjr32